Cargando…
Growth hormone, insulin-like growth factor 1, and insulin signaling—a pharmacological target in body wasting and cachexia
Cachexia is an irreversible process that can develop in the course of chronic disease. It is characterized by the remodeling of the metabolic, inflammatory, and endocrine pathways. Insulin, growth hormone (GH), and insulin-like growth factor 1 (IGF-1) are involved in glucose, protein, and fat metabo...
Autores principales: | Trobec, Katja, von Haehling, Stephan, Anker, Stefan D., Lainscak, Mitja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222822/ https://www.ncbi.nlm.nih.gov/pubmed/22207907 http://dx.doi.org/10.1007/s13539-011-0043-5 |
Ejemplares similares
-
Pharmacokinetics of Drugs in Cachectic Patients: A Systematic Review
por: Trobec, Katja, et al.
Publicado: (2013) -
Cachexia as a major public health problem: frequent, costly, and deadly
por: Farkas, Jerneja, et al.
Publicado: (2013) -
Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2019) -
Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2020) -
Influence of cancer cachexia on drug liver metabolism and renal elimination in rats
por: Cvan Trobec, Katja, et al.
Publicado: (2015)